We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$4.36B
AUM Growth
+$1.42B
Cap. Flow
+$2.09B
Cap. Flow %
47.88%
Top 10 Hldgs %
44.57%
Holding
147
New
40
Increased
52
Reduced
12
Closed
36

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$86.1M
2
TJX icon
TJX Companies
TJX
+$75.5M
3
TVTX icon
Travere Therapeutics
TVTX
+$65.1M
4
AMZN icon
Amazon
AMZN
+$63.1M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$52.3M

Top Sells

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$45.4M
2
ORLY icon
O'Reilly Automotive
ORLY
+$41M
3
ULTA icon
Ulta Beauty
ULTA
+$39.7M
4
FIVE icon
Five Below
FIVE
+$38M
5
FTDR icon
Frontdoor
FTDR
+$32.9M

Sector Composition

Rank Sector Weight
1 Healthcare 46.59%
2 Consumer Staples 10.1%
3 Consumer Discretionary 9.65%
4 Technology 2.31%
5 Industrials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RZLT icon
101
Rezolute
RZLT
$451M
$2.03M 0.05%
288,000
-45,990
-14% -$540K
MDGSW
102
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$1.11M 0.03%
1,285,715
– –
LEXXW
103
DELISTED
Lexaria Bioscience Warrant
LEXXW
$865K 0.02%
+361,905
New +$794K
INM icon
104
InMed Pharmaceuticals
INM
$7.48M
$776K 0.02%
+470
New +$1.01M
SYTAW
105
DELISTED
Siyata Mobile Warrant
SYTAW
$755K 0.02%
150,000
– –
NLSPW
106
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$475K 0.01%
+500,000
New +$455K
GROY.WS
107
DELISTED
Gold Royalty Corp. Warrants, each warrant exercisable for one common share at an exercise price of $7.50
GROY.WS
$470K 0.01%
+448,000
New +$401K
BCTXW
108
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$450K 0.01%
+420,536
New +$412K
GRDX
109
GridAI Technologies Corp
GRDX
$19.5M
– –
0
– –
CUENW
110
DELISTED
Cuentas, Inc. Warrant
CUENW
$46K ﹤0.01%
+50,000
New +$55.6K
AUUDW
111
DELISTED
Auddia Inc Warrants
AUUDW
$21K ﹤0.01%
+30,400
New +$24K
AVNS
112
DELISTED
Avanos Medical
AVNS
– –
-156,000
Closed -$7.16M
AZO icon
113
AutoZone
AZO
$50.1B
– –
-27,589
Closed -$32.7M
BSX icon
114
Boston Scientific
BSX
$69.2B
– –
-500,000
Closed -$18M
BURL icon
115
Burlington
BURL
$23.2B
– –
-97,443
Closed -$25.5M
CRI icon
116
Carter's
CRI
$1.47B
– –
-52,404
Closed -$4.93M
CRWD icon
117
CrowdStrike
CRWD
$214B
– –
-100,000
Closed -$5.3M
DKS icon
118
Dick's Sporting Goods
DKS
$17.9B
– –
-332,389
Closed -$18.7M
EPC icon
119
Edgewell Personal Care
EPC
$1.35B
– –
-336,000
Closed -$11.6M
FTDR icon
120
Frontdoor
FTDR
$5.36B
– –
-656,000
Closed -$32.9M
GOVXW
121
DELISTED
GeoVax Labs Warrants
GOVXW
– –
-391,700
Closed -$887K
KHC icon
122
Kraft Heinz
KHC
$30.5B
– –
-400,000
Closed -$13.9M
LIVN icon
123
LivaNova
LIVN
$4.29B
– –
-172,000
Closed -$11.4M
ORLY icon
124
O'Reilly Automotive
ORLY
$76.3B
– –
-1,358,745
Closed -$41M
PG icon
125
Procter & Gamble
PG
$342B
– –
-87,000
Closed -$12.1M
2 3 4
5
6

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Armistice Capital held 147 positions worth $4.36B, up 48% from $2.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Armistice Capital deployed $2.09B of net new capital in Q1 2021, opening 40 new positions and adding to 52 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 392,000 shares worth $84.2M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Lantheus, an estimated $45.4M trimmed.

  • Armistice Capital's largest Q1 2021 buy was Vertex Pharmaceuticals: 392,000 shares worth $84.2M.
  • Armistice Capital added most to Amazon in Q1 2021, an estimated $63.1M increase.
  • Armistice Capital's biggest Q1 2021 reduction was Lantheus, cutting an estimated $45.4M.
  • Armistice Capital fully exited O'Reilly Automotive in Q1 2021, selling an estimated $41M.
  • Armistice Capital's ten largest holdings make up 45% of its $4.36B portfolio in Q1 2021.
  • Armistice Capital opened 40 new positions and closed 36 in Q1 2021.
  • Armistice Capital's portfolio value rose 48% quarter-over-quarter to $4.36B.

Based on Armistice Capital's 13F filing for Q1 2021, filed 17 May 2021.